Intas Pharmaceuticals Limited Carboplatin Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Carboplatin Export Records India — #3 Exporter, 190 Shipments, $4.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Carboplatin

India Pharmaceutical Trade Intelligence

$70.9M273 Suppliers138 CountriesHS 30049047

ExportsIndia → GERMANY22.6%India → UNITED STATES17.1%

ImportsAUSTRALIA → India$1.1M SOUTH KOREA → India$89.3K

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

Intas Pharmaceuticals Limited — Carboplatin Exporter #3 | $5.8M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Carboplatin Exporter Profile

Indian Pharmaceutical Exporter · #3 for Carboplatin · $5.8M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #3 Indian exporter of Carboplatin with $5.8M in export value and 190 verified shipments. Intas Pharmaceuticals Limited holds a 6.8% market share in Carboplatin exports across 20 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Carboplatin Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Carboplatin export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Carboplatin?

Country	Value	Shipments	Share
MEXICO	$1.7M	37	48.8%
UNITED KINGDOM	$409.8K	19	12.0%
CANADA	$352.7K	11	10.3%
SOUTH AFRICA	$294.0K	9	8.6%
PERU	$193.7K	8

Who Are the Top Buyers of Carboplatin from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
ACCORD FARMA S A DE C V	MEXICO	$579.8K	14
TO THE ORDER	MEXICO	$392.9K	17
ACCORD FARMA S.A. DE C.V.	MEXICO	$349.1K	7
TO THE ORDER .	MEXICO	$200.0K	4
XXCORXXHEAXXHCAXX LTXX	MALTA	$179.6K	10
ACCORD HEALTHCARE LIMITED	MALTA	$179.4K	9
ACCORD HEALTHCARE C/O QESTMED (PTY)	SOUTH AFRICA	$159.2K	5
ACCORD HEALTHCARE INC	CANADA	$155.7K	4
ACCORD FARMA S.A.DE C.V	MEXICO	$150.0K	3
ACCORD HEALTHCARE C/O QESTMED	SOUTH AFRICA	$134.8K	4

Intas Pharmaceuticals Limited supplies Carboplatin to 51 buyers globally. The largest buyer is ACCORD FARMA S A DE C V (MEXICO), followed by TO THE ORDER (MEXICO) and ACCORD FARMA S.A. DE C.V. (MEXICO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Carboplatin Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS AND MEDI NUVAPLAST 150MG/15ML(1X1V) (E1) CARBOPLATIN INJECTION BP 10MG/ML(15 ML) AS PER INV	$250.0K	5
PHAR.DRUGS AND MED: NUVAPLAST 150MG/15ML(1X1V) (E1) CARBOPLATIN INJECTION BP 10MG/ML (15 ML) EACH ML CONTAINS: CARBOPLA	$200.0K	4
CARBOPLATIN INJECTION BP 600MG/60ML	$150.0K	3
PHARMA DRUGS & MEDI ACCORD-CARBOPLATIN 4	$148.8K	4
PHARMACEUTICAL DRUGS AND MEDICINE : NUVAPLAST 450MG/45ML1X1V E1 EACH ML CONTAINS: CARBOPLATIN PH. EUR.. ##### 10 MG	$100.0K	2
PHARMACEUTICAL DRUGS AND MEDICINE : NUVAPLAST 450MG/45ML1X1V E1 EACH ML CONTAINS: CARBOPLATIN PH. EUR.. ##### 10 M	$100.0K	2
PHARMA DRUGS AND MEDI NUVAPLAST 450MG/45ML1X1V E1 EACH ML CONTAINS:CARBOPLATIN PH. EUR.10 MG WATER FOR INJECTIONS PH	$100.0K	2
PH.DRU.& MED. NUVAPLAST 450MG/45ML(1X1V) (E1) EACH ML CONTAINS: CARBOPLATIN PH.EUR 10 MG WATER FOR INJECTIONS	$100.0K	2
PHARMA DRUGS AND MEDI NUVAPLAST 450MG/45ML1X1V E1 EACH ML CONTAINS: CARBOPLATIN PH. EUR. 10 MG WATER FOR INJECTIONS	$71.1K	2
PHARM DRUG &MED:CARBOCORD-450CONE.FOR SOL.FOR.INFUSION EACH ML CONTAINS: CARBOPLATIN PH.EUR 10 MG WATER FOR INJECTIONS	$67.9K	2

Intas Pharmaceuticals Limited exports 139 distinct Carboplatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS AND MEDI NUVAPLAST 150MG/15ML(1X1V) (E1) CARBOP with 5 shipments worth $250.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Carboplatin Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	FRESENIUS KABI ONCOLOGY LIMITED	$27.5M	735	29	$37.5K
3	INTAS PHARMACEUTICALS LIMITED ★	$4.9M	190	20	$25.5K
2	EUGIA PHARMA SPECIALITIES LIMITED	$3.3M	66	3	$50.0K
6	VENUS REMEDIES LIMITED	$2.7M	123	22	$22.0K

Intas Pharmaceuticals Limited ranks #3 among 273 Indian Carboplatin exporters. Average shipment value of $25.5K compared to the market average of $186.1K. The closest competitors by value are FRESENIUS KABI ONCOLOGY LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.

Which Indian Ports Ship Carboplatin Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	648	17.8%
SAHAR AIR	519	14.3%
SAHAR AIR CARGO ACC (INBOM4)	502	13.8%
DELHI AIR	463	12.7%
HYDERABAD AIR	126	3.5%
Bombay Air	119	3.3%
Delhi Air	104	2.9%
HYDERABAD ACC (INHYD4)	99	2.7%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Carboplatin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Carboplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 209 individual customs records matching Intas Pharmaceuticals Limited exporting Carboplatin, covering 139 formulations to 20 countries via 51 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 138+ countries, 829+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Carboplatin

Carboplatin

Intas Pharmaceuticals Limited — Carboplatin Exporter Profile

Intas Pharmaceuticals Limited — Carboplatin Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Carboplatin?

Who Are the Top Buyers of Carboplatin from Intas Pharmaceuticals Limited?

What Is India's Total Carboplatin Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Carboplatin Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Carboplatin Exporters?

What Carboplatin Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Carboplatin to Key Markets

Mexico — COFEPRIS

United Kingdom — MHRA

Canada — HC

How Does Intas Pharmaceuticals Limited Compare to Nearest Carboplatin Exporters?

Which Indian Ports Ship Carboplatin Exports?

What Other Oncology Products Does Intas Pharmaceuticals Limited Export?

Carboplatin — Export Intelligence Video

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Carboplatin Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Carboplatin Export Data from Intas Pharmaceuticals Limited

Carboplatin Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source